These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16494729)

  • 21. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication.
    Wu CH; Yeh SH; Tsay YG; Shieh YH; Kao CL; Chen YS; Wang SH; Kuo TJ; Chen DS; Chen PJ
    J Biol Chem; 2009 Feb; 284(8):5229-39. PubMed ID: 19106108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile.
    Wurtz N; Penant G; Jardot P; Duclos N; La Scola B
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):477-484. PubMed ID: 33389257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
    Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
    Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of RANTES with the replication of severe acute respiratory syndrome coronavirus in THP-1 cells.
    Li D; Wu N; Yao H; Bader A; Brockmeyer NH; Altmeyer P
    Eur J Med Res; 2005 Mar; 10(3):117-20. PubMed ID: 15851378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
    Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; Doerr HW; von Laer D
    J Virol; 2004 Sep; 78(17):9007-15. PubMed ID: 15308697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Sainz B; Mossel EC; Peters CJ; Garry RF
    Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathogenesis of SARS-CoV-2 in human neuronal, microglial and glial cells.
    Kumar N; Santhoshkumar R; Agrawal R; Singh A; Kalyan V; Desai A; Ravi V; Venkataswamy MM
    Arch Microbiol; 2024 Jul; 206(8):345. PubMed ID: 38976047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
    Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
    J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication.
    Ahn DG; Lee W; Choi JK; Kim SJ; Plant EP; Almazán F; Taylor DR; Enjuanes L; Oh JW
    Antiviral Res; 2011 Jul; 91(1):1-10. PubMed ID: 21549154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
    Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
    Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent infection of SARS coronavirus in colonic cells in vitro.
    Chan PK; To KF; Lo AW; Cheung JL; Chu I; Au FW; Tong JH; Tam JS; Sung JJ; Ng HK
    J Med Virol; 2004 Sep; 74(1):1-7. PubMed ID: 15258961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
    Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
    J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
    V'kovski P; Gultom M; Kelly JN; Steiner S; Russeil J; Mangeat B; Cora E; Pezoldt J; Holwerda M; Kratzel A; Laloli L; Wider M; Portmann J; Tran T; Ebert N; Stalder H; Hartmann R; Gardeux V; Alpern D; Deplancke B; Thiel V; Dijkman R
    PLoS Biol; 2021 Mar; 19(3):e3001158. PubMed ID: 33780434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells.
    Mossel EC; Wang J; Jeffers S; Edeen KE; Wang S; Cosgrove GP; Funk CJ; Manzer R; Miura TA; Pearson LD; Holmes KV; Mason RJ
    Virology; 2008 Mar; 372(1):127-35. PubMed ID: 18022664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of SARS-associated coronavirus infection and replication by RNA interference.
    He ML; Zheng B; Peng Y; Peiris JS; Poon LL; Yuen KY; Lin MC; Kung HF; Guan Y
    JAMA; 2003 Nov; 290(20):2665-6. PubMed ID: 14645307
    [No Abstract]   [Full Text] [Related]  

  • 39. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.
    Ren W; Qu X; Li W; Han Z; Yu M; Zhou P; Zhang SY; Wang LF; Deng H; Shi Z
    J Virol; 2008 Feb; 82(4):1899-907. PubMed ID: 18077725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro.
    van Hemert MJ; van den Worm SH; Knoops K; Mommaas AM; Gorbalenya AE; Snijder EJ
    PLoS Pathog; 2008 May; 4(5):e1000054. PubMed ID: 18451981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.